Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Tuesday, September 16, 2025
Dualitas’s $65 Million Series A
AllRock’s $50 Million Series A
Saturday, September 13, 2025
Lila Sciences’s $300 Million Seed Round
Friday, September 12, 2025
Actuate’s $17 Million Public Offering
Thursday, September 11, 2025
Celcuity’s $500 Million Debt Financing
Dianthus’s $288 Million Public Offering
YolTech’s $45 Million Series B
SELLAS’s $24 Million Warrant Exercise
Citius’s $9 Million Registered Direct Offering and Private Placement
Silexion’s $6 Million Public Offering
Wednesday, September 10, 2025
Alnylam’s $575 Million Debt Financing
Odyssey’s $231 Million Series D
Tuesday, September 9, 2025
Novartis’s $1.4 Billion Acquisition of Tourmaline Bio
iRegene’s $40 Million Series B+
Alchemab’s $32 Million Series A
Ridge’s $25 Million Seed Round
Beyond’s $3 Million Warrant Exercise
Monday, September 8, 2025
Harrow’s $250 Million Debt Financing
Talphera’s $29 Million Private Placement
Alterity’s $13 Million Private Placement
Thursday, September 4, 2025
Enveda’s $150 Million Series D
Mesoblast $50 Million Debt Financing
Congruence’s $32 Million Seed Round
Artelos’ $3 Million Public Offering
Wednesday, September 3, 2025
Treeline’s $200 Million Series A
Precigen’s $125 Million Debt Financing
Galvanize’s $100 Million Series C
MicrobiotiX’s $14 Million Series B
Tuesday, September 2, 2025
Royalty’s $300 Million Venture Financing
Mineralys’s $250 Million Public Offering
vTv’s $80 Million Private Placement
PNP Program Partners
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck